Protein responsible for muscle degeneration identified
A study has demonstrated that a certain protein is critical in the decline of muscle regeneration, with the researchers also showing how to inhibit this process in mice.
List view / Grid view
A study has demonstrated that a certain protein is critical in the decline of muscle regeneration, with the researchers also showing how to inhibit this process in mice.
The worldwide market for in vitro toxicology and toxicity testing is predicted to be worth $12.7 billion by the end of the forecast period.
The newly identified variant could play a role in gene therapies that require high accuracy and precision.
New antibiotics could be designed by discovering the mechanism a weapon bacteria uses to vanquish their competitors.
A new study has shown that it is possible to specifically conduct the fate of tissue cells by using visible light.
These findings highlight the complexity of the relationship between genes and human brain function.
Researchers have shown that a monoclonal antibody prevents viruses from fusing with cell membranes to gain entry.
Researchers have used whole genome sequencing to analyse breast cancers and reveal which are more responsive to treatments, which could improve the development of oncologic therapies.
Molecules that are critical for T cells to travel to and populate the lungs have been identified which could strengthen vaccines against influenza.
Researchers have used a high-throughput screening method to test over 125,000 molecules and identify a new class of antibiotics.
The mechanism in the brain connecting chronic pain and depression could lead to treatments for both, according to researchers.
Researchers in the US have devised a new way to clearly image proteins located in synapses, which they hope will faciliate future treatment for diseases associated with blocked gene expression.
A study has revealed that using DNA-like molecules to repair gene mutations in models could act as a successful therapy for patients.
Scientists in the US have developed a promising new CAR T-cell therapy that targets the BAFF-R protein, which has demonstrated superior cancer destruction to existing FDA-approved CAR-T therapies.
The process that bacteria use to defend themselves has been revealed by researchers, who also demonstrated how to activate the process.